Author

Ahmet A. Kurdoglu

Genentech

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:scRNA-seq· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Adrienne HellandiD· 1 shared Ajai ChariiD· 1 shared Alex Blanski· 1 shared Amelia Au‐Yeung· 1 shared Ana Xavier‐MagalhãesiD· 1 shared Andrea Donnelly· 1 shared Andrzej J. JakubowiakiD· 1 shared Austin W. Christofferson· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Adrienne HellandORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Comparative Analysis of Commercial Single-Cell RNA Sequencing Technologies

Marco Claudio De Simone, Jonathan Hoover, Julia Lau, Hayley Bennet, Bing Wu, Cynthia Chen, Hari Menon, Amelia Au‐Yeung, Sean P. Lear, Samir Vaidya, Minyi Shi, Jessica M. Lund, Ana Xavier‐Magalhães, Yuxin Liang, Ahmet A. Kurdoglu, , Spyros Darmanis

This study compares ten commercial scRNA-seq technologies using PBMCs, finding the 10x Genomics kit offers superior performance and the Becton Dickinson kit provides cost-effective performance per cell.

bioRxiv · Jun 18, 2024 · PreprintMolecular Biology

Genomic Basis of Multiple Myeloma Subtypes from the MMRF CoMMpass Study

Sheri Skerget, Daniel Peñaherrera, Ajai Chari, Sundar Jagannath, David Samuel DiCapua Siegel, Ravi Vij, Gregory Joshua Orloff, Andrzej J. Jakubowiak, Rubén Niesvizky, Darla Liles, Jesús G. Berdeja, Moshe Yair Levy, Jeffrey Lee Wolf, Saad Z. Usmani, The MMRF CoMMpass Network, , Jonathan J. Keats

The paper identifies genomic subtypes of multiple myeloma using the MMRF CoMMpass study and finds that 25.5% of patients transition to a high-risk expression subtype at progression, which expresses immunotherapy targets.

medRxiv · Aug 2, 2021 · PreprintGenetic & Genomic Medicine